Literature DB >> 26188957

New continuous-flow total artificial heart and vascular permeability.

Jun Feng1, William E Cohn2, Steven M Parnis2, Neel R Sodha1, Richard T Clements1, Nicholas Sellke1, O Howard Frazier2, Frank W Sellke3.   

Abstract

BACKGROUND: We tested the short-term effects of completely nonpulsatile versus pulsatile circulation after ventricular excision and replacement with total implantable pumps in an animal model on peripheral vascular permeability.
METHODS: Ten calves underwent cardiac replacement with two HeartMate III continuous-flow rotary pumps. In five calves, the pump speed was rapidly modulated to impart a low-frequency pulse pressure in the physiologic range (10-25 mm Hg) at a rate of 40 pulses per minute (PP). The remaining five calves were supported with a pulseless systemic circulation and no modulation of pump speed (NP). Skeletal muscle biopsies were obtained before cardiac replacement (baseline) and on postoperative days (PODs) 1, 7, and 14. Skeletal muscle-tissue water content was measured, and morphologic alterations of skeletal muscle were assessed. VE-cadherin, phospho-VE-cadherin, and CD31 were analyzed by immunohistochemistry.
RESULTS: There were no significant changes in tissue water content and skeletal muscle morphology within group or between groups at baseline, PODs 1, 7, and 14, respectively. There were no significant alterations in the expression and/or distribution of VE-cadherin, phospho-VE-cadherin, and CD31 in skeletal muscle vasculature at baseline, PODs 1, 7, and 14 within each group or between the two groups, respectively. Although continuous-flow total artificial heart (CFTAH) with or without a pulse pressure caused slight increase in tissue water content and histologic damage scores at PODs 7 and 14, it failed to reach statistical significance.
CONCLUSIONS: There was no significant adherens-junction protein degradation and phosphorylation in calf skeletal muscle microvasculature after CFTAH implantation, suggesting that short term of CFTAH with or without pulse pressure did not cause peripheral endothelial injury and did not increase the peripheral microvascular permeability.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adherens-junction protein; Continuous-flow total artificial heart; Tissue edema; Total cardiac replacement device; Vascular permeability

Mesh:

Substances:

Year:  2015        PMID: 26188957      PMCID: PMC4636951          DOI: 10.1016/j.jss.2015.06.035

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  27 in total

Review 1.  Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation.

Authors:  O H Frazier; Nyma A Shah; Timothy J Myers; Kimberly D Robertson; Igor D Gregoric; Reynolds Delgado
Journal:  Cardiology       Date:  2004       Impact factor: 1.869

Review 2.  The MicroMed DeBakey VAD--part I: The pump and the blood flow.

Authors:  Evgenij V Potapov; Andreas Koster; Matthias Loebe; Ewald Hennig; Thomas Fischer; Ralf Sodian; Roland Hetzer
Journal:  J Extra Corpor Technol       Date:  2003-12

3.  Aprotinin preserves cellular junctions and reduces myocardial edema after regional ischemia and cardioplegic arrest.

Authors:  Tanveer A Khan; Cesario Bianchi; Eugenio Araujo; Pierre Voisine; Shu-Hua Xu; Jun Feng; Jian Li; Frank W Sellke
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

4.  Melatonin protects against ischemia/reperfusion injury in skeletal muscle.

Authors:  Korhan Erkanli; Nihan Kayalar; Gözde Erkanli; Feriha Ercan; Göksel Sener; Kaan Kirali
Journal:  J Pineal Res       Date:  2005-10       Impact factor: 13.007

5.  Mechanisms of VE-cadherin processing and degradation in microvascular endothelial cells.

Authors:  Kanyan Xiao; David F Allison; Margaret D Kottke; Susan Summers; George P Sorescu; Victor Faundez; Andrew P Kowalczyk
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

6.  Biochemical and structural evidence for pig myocardium adherens junction disruption by cardiopulmonary bypass.

Authors:  C Bianchi; E G Araujo; K Sato; F W Sellke
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

7.  Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection.

Authors:  O H Frazier; Timothy J Myers; Stephen Westaby; Igor D Gregoric
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

8.  Total heart replacement using dual intracorporeal continuous-flow pumps in a chronic bovine model: a feasibility study.

Authors:  O H Frazier; Egemen Tuzun; William E Cohn; Jeffrey L Conger; Kamuran A Kadipasaoglu
Journal:  ASAIO J       Date:  2006 Mar-Apr       Impact factor: 2.872

9.  First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report.

Authors:  O H Frazier; Reynolds M Delgado; Biswajit Kar; Vijay Patel; Igor D Gregoric; Timothy J Myers
Journal:  Tex Heart Inst J       Date:  2004

Review 10.  Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis.

Authors:  Gianfranco Bazzoni; Elisabetta Dejana
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

View more
  4 in total

1.  Ventricular Assist Device Implantation Configurations Impact Overall Mechanical Circulatory Support System Thrombogenic Potential.

Authors:  Wei-Che Chiu; Yared Alemu; Allison J McLarty; Shmuel Einav; Marvin J Slepian; Danny Bluestein
Journal:  ASAIO J       Date:  2017 May/Jun       Impact factor: 2.872

2.  Calpain inhibition decreases inflammatory protein expression in vessel walls in a model of chronic myocardial ischemia.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Sharif A Sabe; Benedikt J V Braun; Richard T Clements; Anny Usheva; Frank W Sellke
Journal:  Surgery       Date:  2016-12-23       Impact factor: 3.982

Review 3.  The ongoing quest for the first total artificial heart as destination therapy.

Authors:  Annemijn Vis; Maziar Arfaee; Husain Khambati; Mark S Slaughter; Jan F Gummert; Johannes T B Overvelde; Jolanda Kluin
Journal:  Nat Rev Cardiol       Date:  2022-06-06       Impact factor: 32.419

Review 4.  Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass.

Authors:  Jun Feng; Frank Sellke
Journal:  Curr Opin Cardiol       Date:  2016-11       Impact factor: 2.161

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.